Iranian Red Crescent Medical Journal

Published by: Kowsar

The Overestimation of Vancomycin-Associated Nephrotoxicity: The Effect of Rhabdomyolysis and Nephrotoxicants at a Referral Poison Center, Tehran, Iran

Simin Dokht Shoaei 1 , Mohammad Sistanizad 2 , Naser Mozafari 3 , Tahereh Alinia 4 and Haleh Talaie 5 , *
Authors Information
1 Clinical Research and Development Center, Imam Hossein Hospital, Shahid Beheshti University of Medical Sciences, Tehran, IR Iran
2 Department of Clinical Pharmacy, Faculty of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, IR Iran
3 Plastic Surgery Department, 15 Khordad Hospitals, Shahid Beheshti University of Medical Sciences, Tehran, IR Iran
4 Students’ Research Office, Epidemiology Department, Health Faculty, Shahid Beheshti University of Medical Sciences, Tehran, IR Iran
5 Toxicological Research Center, Department of Clinical Toxicology, Loghman-Hakim Hospital, Shahid Beheshti University of Medical Sciences, Tehran, IR Iran
Article information
  • Iranian Red Crescent Medical Journal: October 2016, 18 (10); e59070
  • Published Online: October 2, 2016
  • Article Type: Research Article
  • Received: June 13, 2016
  • Revised: September 20, 2016
  • Accepted: September 20, 2016
  • DOI: 10.5812/ircmj.39969

To Cite: Shoaei S D, Sistanizad M, Mozafari N, Alinia T, Talaie H. The Overestimation of Vancomycin-Associated Nephrotoxicity: The Effect of Rhabdomyolysis and Nephrotoxicants at a Referral Poison Center, Tehran, Iran, Iran Red Crescent Med J. 2016 ; 18(10):e59070. doi: 10.5812/ircmj.39969.

Abstract
Copyright © 2016, Iranian Red Crescent Medical Journal. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Methods
4. Results
5. Discussion
Acknowledgements
Footnote
References
  • 1. Liu C, Bayer A, Cosgrove SE, Daum RS, Fridkin SK, Gorwitz RJ, et al. Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children. Clin Infect Dis. 2011; 52(3): 18-55[DOI][PubMed]
  • 2. Burnham JP, Burnham CD, Warren DK, Kollef MH. Impact of time to appropriate therapy on mortality in patients with vancomycin-intermediate staphylococcus aureus infection. Antimicrob Agents Chem. 2016; 60(9): 5546-53
  • 3. van Hal SJ, Lodise TP, Paterson DL. The clinical significance of vancomycin minimum inhibitory concentration in Staphylococcus aureus infections: a systematic review and meta-analysis. Clin Infect Dis. 2012; 54(6): 755-71[DOI][PubMed]
  • 4. Fullmer A, McCue D, Feng C. Retrospective review of vancomycin-induced nephrotoxicity in patients with leukemia. J Oncol Pharm Pract. 2014; 20(6): 403-8[DOI][PubMed]
  • 5. van Hal SJ, Paterson DL, Lodise TP. Systematic review and meta-analysis of vancomycin-induced nephrotoxicity associated with dosing schedules that maintain troughs between 15 and 20 milligrams per liter. Antimicrob Agents Chemother. 2013; 57(2): 734-44[DOI][PubMed]
  • 6. Elyasi S, Khalili H, Dashti-Khavidaki S, Mohammadpour A. Vancomycin-induced nephrotoxicity: mechanism, incidence, risk factors and special populations. A literature review. Eur J Clin Pharmacol. 2012; 68(9): 1243-55[DOI][PubMed]
  • 7. Elyasi S, Khalili H, Hatamkhani S, Dashti-Khavidaki S. Prevention of vancomycin induced nephrotoxicity: a review of preclinical data. Eur J Clin Pharmacol. 2013; 69(4): 747-54[DOI][PubMed]
  • 8. Lodise TP, Lomaestro B, Graves J, Drusano GL. Larger vancomycin doses (at least four grams per day) are associated with an increased incidence of nephrotoxicity. Antimicrob Agents Chemother. 2008; 52(4): 1330-6[DOI][PubMed]
  • 9. Eswarappa M, Gireesh MS, Ravi V, Kumar D, Dev G. Spectrum of acute kidney injury in critically ill patients: A single center study from South India. Indian J Nephrol. 2014; 24(5): 280-5[DOI][PubMed]
  • 10. Piccinni P, Cruz DN, Gramaticopolo S, Garzotto F, Dal Santo M, Aneloni G, et al. Prospective multicenter study on epidemiology of acute kidney injury in the ICU: a critical care nephrology Italian collaborative effort (NEFROINT). Minerva Anestesiol. 2011; 77(11): 1072-83[PubMed]
  • 11. Zimmermann AE, Katona BG, Plaisance KI. Association of vancomycin serum concentrations with outcomes in patients with gram-positive bacteremia. Pharmacotherapy. 1995; 15(1): 85-91[PubMed]
  • 12. Minejima E, Choi J, Beringer P, Lou M, Tse E, Wong-Beringer A. Applying new diagnostic criteria for acute kidney injury to facilitate early identification of nephrotoxicity in vancomycin-treated patients. Antimicrob Agents Chemother. 2011; 55(7): 3278-83[DOI][PubMed]
  • 13. Rybak MJ, Lomaestro BM, Rotschafer JC, Moellering RC, Craig WA, Billeter M, et al. Vancomycin therapeutic guidelines: a summary of consensus recommendations from the infectious diseases Society of America, the American Society of Health-System Pharmacists, and the Society of Infectious Diseases Pharmacists. Clin Infect Dis. 2009; 49(3): 325-7[DOI][PubMed]
  • 14. Rybak M, Lomaestro B, Rotschafer JC, Moellering RJ, Craig W, Billeter M, et al. Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists. Am J Health Syst Pharm. 2009; 66(1): 82-98[DOI][PubMed]
  • 15. Hassanian-Moghaddam H, Zamani N, Rahimi M, Shadnia S, Pajoumand A, Sarjami S. Acute adult and adolescent poisoning in Tehran, Iran; the epidemiologic trend between 2006 and 2011. Arch Iran Med. 2014; 17(8): 534-8[PubMed]
  • 16. Bellomo R, Ronco C, Kellum JA, Mehta RL, Palevsky P, Acute Dialysis Quality Initiative W. Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care. 2004; 8(4)-12[DOI][PubMed]
  • 17. Pickering JW, Endre ZH. Back-calculating baseline creatinine with MDRD misclassifies acute kidney injury in the intensive care unit. Clin J Am Soc Nephrol. 2010; 5(7): 1165-73[DOI][PubMed]
  • 18. Kouchek M, Asghari R, Mahdavinejad A, Salimi A, Barari B, Seyedrazi P, et al. Comparative study between teicoplanin and vancomycin in methicillin-resistant staphylococcus aureus (mrsa) infectious of toxicological intensive care unit (ticu) patients-tehran iran. Life Sci J. 2014; 11(3s): 83-90
  • 19. Lodise TP, Patel N, Lomaestro BM, Rodvold KA, Drusano GL. Relationship between initial vancomycin concentration-time profile and nephrotoxicity among hospitalized patients. Clin Infect Dis. 2009; 49(4): 507-14[DOI][PubMed]
  • 20. Cimino MA, Rotstein C, Slaughter RL, Emrich LJ. Relationship of serum antibiotic concentrations to nephrotoxicity in cancer patients receiving concurrent aminoglycoside and vancomycin therapy. Am J Med. 1987; 83(6): 1091-7
  • 21. Elting LS, Rubenstein EB, Kurtin D, Rolston K, Fangtang J, Martin C, et al. Mississippi mud in the 1990s. Cancer. 1998; 83(12): 2597-607
  • 22. Cano EL, Haque NZ, Welch VL, Cely CM, Peyrani P, Scerpella EG, et al. Incidence of nephrotoxicity and association with vancomycin use in intensive care unit patients with pneumonia: retrospective analysis of the IMPACT-HAP Database. Clin Ther. 2012; 34(1): 149-57[DOI][PubMed]
  • 23. Matson KL, Shaffer CL, Beck GL, Simonsen KA. Assessment of initial serum vancomycin trough concentrations and their association with initial empirical weight-based vancomycin dosing and development of nephrotoxicity in children: a multicenter retrospective study. Pharmacotherapy. 2015; 35(3): 337-43[DOI][PubMed]
  • 24. Jeffres MN, Isakow W, Doherty JA, Micek ST, Kollef MH. A retrospective analysis of possible renal toxicity associated with vancomycin in patients with health care-associated methicillin-resistant Staphylococcus aureus pneumonia. Clin Ther. 2007; 29(6): 1107-15[DOI][PubMed]
  • 25. Prabaker KK, Tran TP, Pratummas T, Goetz MB, Graber CJ. Elevated vancomycin trough is not associated with nephrotoxicity among inpatient veterans. J Hosp Med. 2012; 7(2): 91-7[DOI][PubMed]
  • 26. Ackerman BH, Guilday RE, Reigart CL, Patton ML, Haith LR. Evaluation of the relationship between elevated vancomycin trough concentrations and increased efficacy and/or toxicity. J Burn Care Res. 2013; 34(1): 1-9[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments